Zhejiang Shapuaisi Pharmaceutical Co Ltd Asset Resilience Ratio
Zhejiang Shapuaisi Pharmaceutical Co Ltd asset resilience ratio. Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) has an Asset Resilience Ratio of 5.74% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Zhejiang Shapuaisi Pharmaceutical Co Ltd (603168) defensive interval to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Zhejiang Shapuaisi Pharmaceutical Co Ltd (2008–2024)
Asset resilience ratio of Zhejiang Shapuaisi Pharmaceutical Co Ltd from 2008 to 2024. This chart shows how Zhejiang Shapuaisi Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Read Zhejiang Shapuaisi Pharmaceutical Co Ltd debt and liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Zhejiang Shapuaisi Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of Zhejiang Shapuaisi Pharmaceutical Co Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥122.39 Million | 5.74% |
| Total Liquid Assets | CN¥122.39 Million | 5.74% |
Asset Resilience Insights
- Limited Liquidity: Zhejiang Shapuaisi Pharmaceutical Co Ltd maintains only 5.74% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Zhejiang Shapuaisi Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Zhejiang Shapuaisi Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Takeda Pharmaceutical Company Limited
F:TKDA |
Drug Manufacturers - Specialty & Generic | 0.69% |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK |
Drug Manufacturers - Specialty & Generic | 4.94% |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Ajanta Pharma Limited
NSE:AJANTPHARM |
Drug Manufacturers - Specialty & Generic | 14.99% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Jiangsu Nhwa Pharmaceutical Co Ltd
SHE:002262 |
Drug Manufacturers - Specialty & Generic | 26.45% |
|
Porton Fine Chemicals Ltd
SHE:300363 |
Drug Manufacturers - Specialty & Generic | 6.85% |
|
Jubilant Pharmova Limited
NSE:JUBLPHARMA |
Drug Manufacturers - Specialty & Generic | 1.26% |
Zhejiang Shapuaisi Pharmaceutical Co Ltd Asset Resilience Ratio by Year (2008–2024)
Zhejiang Shapuaisi Pharmaceutical Co Ltd asset resilience ratio by year from 2008 to 2024. The table below shows the annual Asset Resilience Ratio data for Zhejiang Shapuaisi Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 5.07% | CN¥106.86 Million ≈ $15.64 Million |
CN¥2.11 Billion ≈ $308.21 Million |
+4.45pp |
| 2023-12-31 | 0.62% | CN¥13.53 Million ≈ $1.98 Million |
CN¥2.17 Billion ≈ $317.58 Million |
-0.87pp |
| 2022-12-31 | 1.50% | CN¥29.27 Million ≈ $4.28 Million |
CN¥1.96 Billion ≈ $286.47 Million |
-5.13pp |
| 2021-12-31 | 6.63% | CN¥105.03 Million ≈ $15.37 Million |
CN¥1.59 Billion ≈ $231.99 Million |
-8.32pp |
| 2020-12-31 | 14.94% | CN¥250.00 Million ≈ $36.58 Million |
CN¥1.67 Billion ≈ $244.80 Million |
-1.42pp |
| 2019-12-31 | 16.36% | CN¥260.00 Million ≈ $38.05 Million |
CN¥1.59 Billion ≈ $232.57 Million |
-10.94pp |
| 2018-12-31 | 27.30% | CN¥450.00 Million ≈ $65.85 Million |
CN¥1.65 Billion ≈ $241.24 Million |
+20.34pp |
| 2017-12-31 | 6.95% | CN¥130.00 Million ≈ $19.02 Million |
CN¥1.87 Billion ≈ $273.55 Million |
-3.90pp |
| 2016-12-31 | 10.86% | CN¥200.00 Million ≈ $29.27 Million |
CN¥1.84 Billion ≈ $269.56 Million |
+1.69pp |
| 2014-12-31 | 9.17% | CN¥80.00 Million ≈ $11.71 Million |
CN¥872.34 Million ≈ $127.65 Million |
+9.09pp |
| 2008-12-31 | 0.09% | CN¥138.68K ≈ $20.29K |
CN¥162.82 Million ≈ $23.83 Million |
-- |
About Zhejiang Shapuaisi Pharmaceutical Co Ltd
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products. The company provides its products to ophthalmology, antimicrobials, gynecology, and other classes. It offers its products in injections, oral solutions, eye drops, large-volume injections, oral solutions, tablets, granules, and other dosage forms. Zhejiang Shapuaisi… Read more